AI: Technology, News & Trends
AI Runways Reshape the Fashion Industry: Creative Boundaries and New Brand Challenges
At the 2026 World Economic Forum Annual Meeting, Elon Musk’s prediction that AI will surpass human experts in specific tasks is gradually coming...
OpenAI Launches macOS Codex App
In the technology landscape of 2026, artificial intelligence has deeply integrated into software development, completely transforming traditional programming methods. According to a report...
Google Expands AI Plus to 35 Markets
Google recently announced that its AI Plus subscription service will be expanded to 35 new markets, including the United States, at a monthly...
From Clawdbot to Moltbot: The AI Assistant Taking Silicon Valley by Storm
Recently, an AI tool named Moltbot (formerly known as Clawdbot) has swept across Silicon Valley. Both the heated discussions in geek communities and...
DeepSeek Launches Next-Gen OCR Model
Recently, DeepSeek officially released its multimodal visual understanding model DeepSeek-OCR 2. According to the latest news, the model is built on the new...
NVIDIA Invests $2B in CoreWeave for AI Factories
NVIDIA and cloud services provider CoreWeave have recently reached a strategic cooperation agreement. According to the agreement, the two parties will engage in...
Alibaba Launches Qwen3-Max-Thinking, Rivaling GPT-5.2
In early 2026, Alibaba officially launched Qwen3-Max-Thinking, its most advanced large language model to date. The model has set new records across multiple...
OpenAI Bets on Screenless AI Pen: New Hardware
In the mainstream narrative of technological evolution, the linear logic of “bigger, faster, smarter” has long dominated consumer electronics. From smartphones and tablets...
OpenAI to Launch First Hardware Device in 2026
At the globally watched Davos Forum, Chris Lehane, OpenAI’s Head of Global Affairs, revealed the latest news that the company plans to release...
The World’s First AI-Designed Antibody Enters Phase III Clinical Trials
In December 2025, GB-0895, the world’s first fully AI-designed antibody drug developed by Generate Biomedicines, officially initiated Phase III clinical trials. This milestone...